The Quantellect read.As of Nov 19, 2026, 20 active firms cover DexCom Inc: 18 rate it Buy or better, 2 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets span $80.00 to $115.00, a moderate spread. The average target of $93.41 sits 13% above the current $82.56. Sentiment has drifted a little more constructive lately, with Sell ratings easing from 1 to 0 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.64 next quarter toward $3.13 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS20 active firms
Buy
Strong Buy00%
Buy1890%
Neutral210%
Sell00%
Strong Sell00%
Based on 20 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$93.41
+13.2% upside
Average target across 17 active firms as of Nov 19, 2026 vs $82.56 current
Highest Target$115.00
Average Target$93.41
Lowest Target$80.00
Detailed analyst forecasts for DXCM
Showing 1–19 of 19 named analysts shown · 20 active firms in the rating projection
As of Nov 19, 2026, 18 of 20 active firms rate DXCM a Buy (2 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
DXCM EPS & revenue forecast
EPS · NEXT QUARTER
$0.64
Range $0.57 – $0.74 · 17 analysts · +14% YoY
Next period, 17 analysts expect DexCom Inc to earn $0.64 a share (range $0.57 – $0.74), versus $0.56 a year earlier. Full-year consensus is $2.70, growing to $3.13 the year after.
REVENUE · NEXT QUARTER
$1.3B
Range $1.3B – $1.3B · 17 analysts · +10% YoY
Revenue is expected to reach $1.3B (range $1.3B – $1.3B), +10.1% year-over-year. Full-year consensus is $5.2B, rising to $5.8B next year.
Top analysts covering DexCom Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on DXCM.
#1
Joanne Wuensch
Citigroup · Rank #35
Buy
$105.00+27.2% to target
Overall win rate
51%
+ Follow
#2
Anthony Petrone
Mizuho · Rank #121
Buy
$100.00+21.1% to target
Overall win rate
45%
+ Follow
#3
JB
Jayson Bedford
Raymond James · Rank #191
Buy
$94.00+13.9% to target
Overall win rate
44%
+ Follow
#4
Ryan Zimmerman
BTIG · Rank #212
Buy
$96.00+16.3% to target
Overall win rate
37%
+ Follow
#5
Jonathan Block
Stifel · Rank #294
Buy
$95.00+15.1% to target
Overall win rate
36%
+ Follow
DXCM stock forecast FAQ
What is DXCM's average 12-month price target?+
The 17 active firms with a live target average $93.41 for DexCom Inc over the next 12 months, ranging from a $115.00 high to a $80.00 low, as of Nov 19, 2026.
Is DXCM stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 20 active firms as of Nov 19, 2026, 18 rate it Buy or Strong Buy, 2 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for DXCM?+
The Street-high target is $115.00 (Barclays), and the Street-low is $80.00 (B of A Securities). The average of all 17 active-firm targets is $93.41.
How many active Wall Street firms cover DXCM?+
20 active firms have a recognized rating on DexCom Inc as of Nov 19, 2026, and 17 active firms carry a live 12-month price target.
Who is the most accurate analyst covering DXCM?+
Among analysts who currently cover DXCM, Joanne Wuensch of Citigroup has the strongest overall Quantellect track record (Rank #35). Their current call is Buy with a $105.00 target.
What is DexCom Inc's projected EPS for next quarter?+
The consensus estimate is $0.64 per share (range $0.57 – $0.74) across 17 analysts. Full-year EPS is projected at $2.70, rising to $3.13 the following year.
How much revenue is DexCom Inc expected to report next quarter?+
Consensus revenue is $1.3B (range $1.3B – $1.3B). Full-year revenue is projected at $5.2B, growing to $5.8B next year.
Have analysts been upgrading or downgrading DXCM lately?+
As of Nov 19, 2026, 18 of 20 active firms rate DXCM a Buy (2 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their DXCM calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.